cyprotex

We are the world leader in predictive toxicology and ADME research with several proprietary technologies and laboratories in the UK and US.

[cyprotex @cyprotex]

Even the most sophisticated AI/ML models are only as good as the data behind them. That’s why at Cyprotex, we deliver high-quality, standardized ADME-Tox datasets essential for drug discovery model training.
Download our latest service sheet to learn more
https://t.co/QUVAnHImAa

[cyprotex @cyprotex]

That’s a wrap on NYSCC Suppliers’ Day in New York!

Ralf, AVP Business Development at Cyprotex, is on-site meeting partners and exchanging ideas. If you didn’t get a chance to connect during the show, or you're still in New York and would like to chat, we’d love to meet up!

[cyprotex @cyprotex]

While statins are a cornerstone in cardiovascular care, side effects such as statin-associated myopathy remain a concern.

But what happens when statin-related transporters are inhibited by a co-medication?

Read more in our latest blog: https://t.co/c0b2Mx9b3t

[cyprotex @cyprotex]

Heading to the BTS Annual Congress 2025? So are we!

Catch us at The Spine, Liverpool, from May 7–9, where our experts, Paul Walker and Julie Eakins, will be presenting our latest work in toxicology research.

Interested? Reach out at [email protected] to schedule a meeting.

[cyprotex @cyprotex]

This year at SOT 2025, we had the chance to connect, collaborate, and exchange ideas with industry leaders. If you couldn’t attend, you can still download our latest research and stay informed.

Read our latest newsletter to learn more: https://t.co/rUu7qjf4Ns

[cyprotex @cyprotex]

From April 2-4, 2025, our team will be in Boston for the Bio-IT World Conference & Expo, where experts in AI, ML, and data-driven innovation will come together to shape the future of life sciences.

Contact us at [email protected] to schedule a discussion with our experts.

[cyprotex @cyprotex]

Drug toxicity is a leading cause of failure in development. Early toxicity identification can change that. At Cyprotex, we use advanced in vitro models to identify safety risks early— ensuring the safest compounds reach the clinic.
Learn more here: https://t.co/fmNp8t5mpF

[cyprotex @cyprotex]

A deep understanding of ADME is essential for successful drug discovery and development. Now updated with the latest ICH M12 guidelines, the 6th edition of Cyprotex’s ADME Guide is here for you to explore more.

Download your free copy today! https://t.co/xshDLJftKi

[cyprotex @cyprotex]

Download your free copy today! https://t.co/aWRMhj5okR

[cyprotex @cyprotex]

The 4th edition of Cyprotex’s DDI Guide breaks down the impact of the latest ICH M12 guidelines on your DDI studies — helping you navigate with clarity and confidence.

#cyprotex #theadmetoxspecialists

[cyprotex @cyprotex]

Located in Framingham, MA, our state-of-the-art ADME-Tox facility is perfectly positioned within the vibrant Boston biotech corridor.

If you are a MassBio member, click here for an exclusive discount on our e-Store: https://t.co/Rm0tU1ROkq

[cyprotex @cyprotex]

Wishing you a joyful holiday season filled with warmth, happiness, and bright new beginnings.

From all of us at Cyprotex, happy holidays and a wonderful new year! 🎄✨

[cyprotex @cyprotex]

Confidently assess the skin sensitization potential of your test articles with Cyprotex’s OECD-compliant in vitro services. Our comprehensive suite of assays includes: KeratinoSens™, U-SENS™, and DPRA.

Contact us to discuss your project: [email protected]

[cyprotex @cyprotex]

Evotec SE announced that its #DrugDiscovery accelerator with Novo Nordisk, LAB eN², has selected its first three projects to move forward in the program.

To learn more, read the full press release here-
https://t.co/3bGOZACNJb

#TogetherForMedicinesThaMatter

[cyprotex @cyprotex]

Our T-Cell Immunogenicity Risk Panel delivers critical data on the human immune response triggered by your biotherapeutic. By measuring IL-2 and IFN-γ release from PBMCs, we enable you to identify T-cell mediated immunogenic risks with better precision.

#cyprotex #immunotox

[cyprotex @cyprotex]

Drug toxicity is a leading cause of failure in development. Early toxicity identification can change that. At Cyprotex, we use advanced in vitro models to identify safety risks early—ensuring the safest compounds reach the clinic.

Learn more: https://t.co/ZwSSZXAN3E

[cyprotex @cyprotex]

Join Cyprotex expert Chris Strock PhD next week at #ACT2025 his presentation as part of the session "Tox Hack: Unleashing the Power of AI and Machine Learning".

Meet us at Booth 318! Book a meeting or learn more here - https://t.co/6qp4CxZuXm

#ACT2025 #toxicology

[cyprotex @cyprotex]

Evotec and Cyprotex will showcase our latest advancements in Bioanalysis at EBF.
View our scientific program and request a meeting https://t.co/tpb96NMX7z
#EBF2024 #PrecisionBioanalysis #DrugDiscovery #DrugDevelopment #BioanalyticalResearch

[cyprotex @cyprotex]

Derisk your projects better, faster, and safer. Meet our Safety Assessment and ADME-Tox experts at ACT this November in Austin!
Learn More & Schedule a Meeting: https://t.co/YsmyauWNWV

#ACT2024 #Toxicology #SafetyAssessment #ADMETox

[cyprotex @cyprotex]

Did you know that cold storage units, particularly ultra-low temperature (ULT) freezers installed in our laboratories use an incredible amount of energy?
Read our blog to learn more- https://t.co/lIwZFBlSDx

#EnvironmentalSustainability #FreezerChallenge #SustainabilityGoals